Taiyen Biotech Co Ltd (1737) — Cash Flow-to-Debt Ratio
Taiyen Biotech Co Ltd (1737) has a Cash Flow-to-Debt Ratio of 0.13x as of December 2025, meaning its operating cash flow of NT$194.08 Million could theoretically repay 0% of its total liabilities (NT$1.45 Billion) in one year. See cash generation quality of Taiyen Biotech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Taiyen Biotech Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Taiyen Biotech Co Ltd across 23 annual periods. Also explore 1737 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Taiyen Biotech Co Ltd. For market capitalisation and broader financial context, see Taiyen Biotech Co Ltd (1737) total market value.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | NT$473.77 Million | NT$1.45 Billion | ▼ -15.1% |
| 2024 | 0.39x | NT$660.12 Million | NT$1.71 Billion | ▲ +50.1% |
| 2023 | 0.26x | NT$454.54 Million | NT$1.77 Billion | ▼ -31.5% |
| 2022 | 0.37x | NT$580.69 Million | NT$1.55 Billion | ▲ +22.0% |
| 2021 | 0.31x | NT$600.08 Million | NT$1.95 Billion | ▲ +29.7% |
| 2020 | 0.24x | NT$339.36 Million | NT$1.43 Billion | ▲ +3.7% |
| 2019 | 0.23x | NT$330.81 Million | NT$1.45 Billion | ▼ -40.6% |
| 2018 | 0.38x | NT$449.83 Million | NT$1.17 Billion | ▼ -22.3% |
| 2017 | 0.49x | NT$607.87 Million | NT$1.23 Billion | ▼ -7.1% |
| 2016 | 0.53x | NT$568.06 Million | NT$1.07 Billion | ▲ +37.3% |
| 2015 | 0.39x | NT$383.93 Million | NT$990.08 Million | ▼ -4.6% |
| 2014 | 0.41x | NT$371.06 Million | NT$913.15 Million | ▼ -12.7% |
| 2013 | 0.47x | NT$203.21 Million | NT$436.66 Million | ▲ +3.2% |
| 2012 | 0.45x | NT$154.46 Million | NT$342.49 Million | ▼ -34.7% |
| 2011 | 0.69x | NT$246.09 Million | NT$356.53 Million | ▼ -15.3% |
| 2010 | 0.81x | NT$300.89 Million | NT$369.36 Million | ▼ -25.1% |
| 2009 | 1.09x | NT$358.02 Million | NT$329.10 Million | ▼ -20.2% |
| 2008 | 1.36x | NT$417.51 Million | NT$306.42 Million | ▲ +55.5% |
| 2007 | 0.88x | NT$322.49 Million | NT$367.92 Million | ▼ -5.9% |
| 2006 | 0.93x | NT$462.88 Million | NT$497.10 Million | ▲ +49.7% |
| 2005 | 0.62x | NT$575.91 Million | NT$925.79 Million | ▼ -56.3% |
| 2004 | 1.42x | NT$2.84 Billion | NT$1.99 Billion | ▲ +73.3% |
| 2003 | 0.82x | NT$3.42 Billion | NT$4.16 Billion | — |